By Regulatory Approvals — Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead Fierce Biotech
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 11, 2026.